Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia

NCT00639483 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer